PLD2 and female reproductive organ cancer: Common regulatory hubs across gynecologic cancers include hypoxic conditions, cell-cycle regulators such as the DREAM complex, stemness-associated pathways exemplified by the HIF-1α/PLD2 axis, and stromal cell interactions, notably cancer-associated fibroblast-extracellular matrix crosstalk.